Understanding what autoimmune diseases are, what triggers them and how they’re treated can be a powerful first step toward ...
Jan 5 () - Zenas BioPharma said on Monday its experimental drug cut the risk of disease flare-ups in a late-stage study of ...
Techno-Science.net on MSN
Fine particles associated with modifications to our immune system
A new study has established a link between exposure to atmospheric pollution and modifications to the immune system that ...
Hutchmed is preparing to file for approval of a drug for the rare autoimmune disorder warm antibody autoimmune haemolytic ...
Hutchmed has continued to test sovleplenib in wAIHA in parallel, culminating in the delivery of data from a Chinese phase 3 ...
A phase 3 study of Zenas BioPharma's autoimmune disease candidate has hit its primary endpoint. But, with the result falling ...
Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...
Following the FDA approval of rilzabrutinib (Wayrilz; Sanofi) for immune thrombocytopenia (ITP), a rare autoimmune disorder, David Kuter, MD, DPhil, highlights the most pressing a ...
The buyout is a bet by Lilly on an increasingly popular drug target known as NLRP3 inflammasomes, which are implicated in an ...
JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 ...
The collaboration with Sanofi focuses on developing bispecific antibodies for autoimmune diseases, leveraging predictive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback